Salivary Gland Tumor Treatment in Chennai

No, most salivary gland tumors are benign (non-cancerous). About 80% of parotid tumors and 50% of submandibular tumors are benign. The most common is pleomorphic adenoma. However, even benign tumors need surgical removal as they can grow large or rarely transform to cancer. Dr. Vidhyadharan evaluates each tumor to determine if it's benign or malignant.

Temporary facial weakness can occur in 10-20% of patients due to nerve manipulation during surgery, but permanent weakness is rare (1-2%) in experienced hands. Dr. Vidhyadharan uses intraoperative nerve monitoring and meticulous surgical technique to minimize this risk. Any temporary weakness usually recovers within weeks to months.

The parotid gland is divided into superficial (80%) and deep (20%) lobes by the facial nerve. Superficial parotidectomy removes only the outer lobe and is sufficient for most benign tumors. Total parotidectomy removes both lobes and is needed for deep lobe tumors or malignancies. Dr. Vidhyadharan determines the appropriate extent based on tumor location and type.

Diagnosis involves clinical examination, imaging (MRI is best for parotid tumors), and fine needle aspiration cytology (FNAC). MRI shows tumor location relative to the facial nerve. FNAC provides preliminary diagnosis. Final diagnosis comes from pathology after surgical removal. Dr. Vidhyadharan correlates all findings for accurate treatment planning.

The exact cause is unknown for most salivary gland tumors. Risk factors include radiation exposure, smoking (for Warthin's tumor), and certain occupational exposures. Unlike oral cancer, tobacco/betel use is not a major cause. HPV may play a role in some types. Most patients have no identifiable risk factor.

Frey's syndrome (gustatory sweating) occurs when regenerating nerve fibers intended for saliva production mistakenly connect to sweat glands. This causes facial sweating while eating. It can occur months after parotid surgery. Prevention involves placing tissue barriers during surgery. Treatment includes Botox injections if symptoms are bothersome.

Yes, surgical removal is recommended for almost all parotid tumors. Reasons include: accurate diagnosis (FNAC isn't 100% reliable), prevention of continued growth, rare risk of malignant transformation in long-standing tumors, and cosmetic concerns. Observation is only considered for very small tumors in elderly/unfit patients.

Adenoid cystic carcinoma is a malignant salivary gland tumor known for perineural invasion (growing along nerves) and slow but persistent behavior. It requires wide surgical excision, often followed by radiation. Long-term follow-up is essential as late recurrences can occur. Dr. Vidhyadharan provides comprehensive management for this challenging tumor.

Hospital stay is typically 2-3 days. Drain is removed when output is minimal. Sutures come out in 7-10 days. Return to light work: 1-2 weeks. Full recovery: 4-6 weeks. Facial nerve function is monitored during this time. Most patients have minimal long-term effects with proper surgical technique.

The incision is placed in natural skin creases around the ear and extends into the neck, similar to a facelift incision. It heals well and becomes barely visible over time. Dr. Vidhyadharan uses meticulous closure techniques to optimize cosmetic outcome. Hair covers much of the scar.

Benign tumors like pleomorphic adenoma can recur if incompletely removed, which is why complete excision with margins is important. Malignant tumors have higher recurrence risk, especially if high-grade or with positive margins. Adjuvant radiation reduces recurrence risk. Regular follow-up detects any recurrence early.

Cost depends on tumor type, surgical extent, need for nerve grafting or reconstruction, and hospital stay duration. THANC Hospital offers comprehensive salivary gland tumor care with transparent pricing. Insurance coverage is available. Detailed estimates are provided after initial evaluation and imaging review.